Anika Therapeutics (ANIK) Current Deferred Tax Assets (2010 - 2015)

Anika Therapeutics (ANIK) has 6 years of Current Deferred Tax Assets data on file, last reported at $1.4 million in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 113.85% year-over-year to $1.4 million in Q3 2015; TTM through Sep 2015 was $1.4 million, a 113.85% increase from a year earlier, with the FY2014 full-year figure at $1.2 million, up 80.38% from the prior year.
• Current Deferred Tax Assets for Q3 2015 stood at $1.4 million, down from $1.5 million in the prior quarter.
• Over the last five years, Current Deferred Tax Assets for ANIK reached as high as $2.0 million in Q4 2012 and fell as low as $659040.0 in Q4 2013.
• Historically, Current Deferred Tax Assets has averaged $1.5 million across 5 years, with a median of $1.9 million in 2011.
• Across the five-year window, Current Deferred Tax Assets plunged 67.56% in 2013 and surged 125.76% in 2015, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $1.9 million in 2011, then gained by 5.87% to $2.0 million in 2012, then plunged by 67.56% to $659040.0 in 2013, then surged by 80.38% to $1.2 million in 2014, then climbed by 18.55% to $1.4 million in 2015.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $1.4 million in Q3 2015, $1.5 million in Q2 2015, and $1.5 million in Q1 2015.